Literature DB >> 11641449

Gene expression of SERCA2a and L- and T-type Ca channels during human heart development.

Y Qu1, M Boutjdir.   

Abstract

In this study we report, for the first time, on the gene expression of human cardiac SERCA2a, L-type (alpha(1C)) and T-type (alpha(1H)) Ca channels during development, using RNase protection assay, relative quantitative RT-PCR and Western blot. Human hearts during early gestation (8- to 20-wk gestation), neonatal (1- to 4-d-old) and adult (18- to 48-year-old) stages were used. The results show that T-type Ca channel alpha(1H) subunit mRNA decreased and that L-type Ca channel alpha(1C) subunit mRNA increased with development. While the levels of sarcoplasmic reticulum ATPase (SERCA2a) mRNA did not significantly change with development, its protein levels increased with development. In conclusion, SERCA2a, L-type and T-type Ca channel transcripts were detected as early as 8-wk gestation. Defining the profile of Ca handling proteins during development is important to the understanding of excitation-contraction (EC)-coupling of the developing human heart.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11641449     DOI: 10.1203/00006450-200111000-00006

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  19 in total

Review 1.  Low-voltage-activated ("T-Type") calcium channels in review.

Authors:  Anne Marie R Yunker; Maureen W McEnery
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

2.  Cardiac repolarization instability during normal postnatal development.

Authors:  Salim F Idriss; Jamie A Bell
Journal:  J Electrocardiol       Date:  2008-09-19       Impact factor: 1.438

3.  Perinatal and postnatal expression of Cav1.3 α1D Ca²⁺ channel in the rat heart.

Authors:  Yongxia Qu; Eddy Karnabi; Omar Ramadan; Yuankun Yue; Mohamed Chahine; Mohamed Boutjdir
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

4.  Truncation of murine CaV1.2 at Asp 1904 increases CaV1.3 expression in embryonic atrial cardiomyocytes.

Authors:  Jie Ding; Katrin Domes; Franz Hofmann; Jörg W Wegener
Journal:  Pflugers Arch       Date:  2013-01-22       Impact factor: 3.657

5.  Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs.

Authors:  Kathy Ye Morgan; Lauren Deems Black
Journal:  Tissue Eng Part A       Date:  2014-04-07       Impact factor: 3.845

Review 6.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

7.  Postnatal developmental changes in the sensitivity of L-type Ca2+ channel to inhibition by verapamil in a mouse heart model.

Authors:  Hironori Sagawa; Shinsuke Hoshino; Kengo Yoshioka; Wei-Guang Ding; Mariko Omatsu-Kanbe; Masao Nakagawa; Yoshihiro Maruo; Hiroshi Matsuura
Journal:  Pediatr Res       Date:  2018-04-18       Impact factor: 3.756

8.  NFAT5-mediated CACNA1C expression is critical for cardiac electrophysiological development and maturation.

Authors:  Wei Li; Nai-Zhong Zheng; Qi Yuan; Ke Xu; Fan Yang; Lei Gu; Gu-Yan Zheng; Guo-Jie Luo; Chun Fan; Guang-Ju Ji; Bo Zhang; Huiqing Cao; Xiao-Li Tian
Journal:  J Mol Med (Berl)       Date:  2016-07-01       Impact factor: 4.599

9.  Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.

Authors:  Hui Gao; Fang Wang; Wei Wang; Catherine A Makarewich; Hongyu Zhang; Hajime Kubo; Remus M Berretta; Larry A Barr; Jeffery D Molkentin; Steven R Houser
Journal:  J Mol Cell Cardiol       Date:  2012-08-21       Impact factor: 5.000

10.  Ca2+ influx through T- and L-type Ca2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes.

Authors:  Naser Jaleel; Hiroyuki Nakayama; Xiongwen Chen; Hajime Kubo; Scott MacDonnell; Hongyu Zhang; Remus Berretta; Jeffrey Robbins; Leanne Cribbs; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2008-10-02       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.